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ABSTRACT
Objective: The objective of this study was to investigate the antihypertensive activity of heterocyclic compounds against angiotensin-converting 
enzyme (ACE) through molecular docking studies.
Methods: The X-ray crystal three-dimensional (3D) structure of human ACE complexed with lisinopril (PDB ID: 1O86) was retrieved from protein 
databank. The two-dimensional structures of 10 selected heterocyclic compounds were drawn in ACD-Chemsketch and converted into 3D structures. 
The 3D structures of compounds were virtually screened in the binding pockets of ACE using FlexX docking program. Further, the chemical entities 
revealing the molecular electronic structures of the best docked compound (Compound-4) were explored through density functional theory studies.
Results: The Compound-4 showed the highest docking score of −26.6290 kJ/mol with ACE. The Hbond and non-bonded interactions are favored 
by phenylalanine, leucine, and arginine. The energy gap of 1.60 eV between highest occupied molecular orbital and lowest unoccupied molecular 
orbitals explained the presence of strong electron-acceptor group. Furthermore, the molecular electrostatic potential studies clearly envisaged the 
requirement of electropositive and electronegative groups are crucial for the ACE inhibitor activities.
Conclusion: The identification of good ACE inhibitors requires the understanding of the current ACE inhibitors. Thus, the docking interactions of 
Compound-4 and its molecular electronic structure significantly imply its potential as antihypertensive agent. However, further clinical studies are 
required to ascertain its potential toxic effects.
Keywords: Angiotensin-converting enzyme, Angiotensin-converting enzyme inhibitors, Docking, Density functional theory studies, Highest occupied 
molecular orbital, Lowest unoccupied molecular orbitals, Molecular electrostatic potentials.
INTRODUCTION
In recent years, cardiovascular diseases have become a serious problem 
worldwide. The World Health Organization has reported an increase in 
the number of patients suffering from this disease. Hypertension is an 
important risk factor, contributing to other cardiovascular diseases such 
as blood vessel disorders, coronary heart disease, aortic aneurysm, and 
stroke [1]. Cardiac arrhythmia is another cardiovascular problem. An 
arrhythmia is any disorder of the heart rate that may cause stroke. Heart 
rhythm’s disorders may be caused by genetic factors or occur when the 
heart muscle (myocardium) is damaged, sometimes by hypertension [2].
At present, existing treatments for high blood pressure (BP) are not 
very effective and are generally uncomfortable for patients. This relies 
in that the patient needs to have a very strict control in the dosage and in 
the moment of the administration of the drug [3]. Moreover, also, some 
patients have an unfavorable response after the administration, leading 
them to a fast BP reduced. One of the most widely used compounds for 
the treatment of hypertension is Captopril. Like many others on the 
market, this drug was designed with computational tools. Over the past 
few decades, computational studies, together with rational drug design, 
have become a critical part in the development of new drugs.
Raised BP, especially systolic pressure (hypertension), confers 
a significant cardiovascular risk and public health concern and 
should be actively treated. One of the major systems involved in the 
elevation of the pressure is the renin–angiotensin system (RAS), and 
subsequently, its inhibition will have beneficial effects to lower BP and 
improve cardiovascular health [4]. The RAS is regulated by a series 
of highly specific enzymatic reactions. The first enzymatic reaction 
in the pathway starts with renal production of renin that cleaves 
angiotensinogen to generate angiotensin I. Angiotensin I is then cleaved 
by angiotensin-converting enzyme (ACE) to generate the active peptide 
vasoconstrictive hormone angiotensin II.
Many ACE inhibitors are known to be useful in the treatment of 
hypertension. The search for ACE inhibitors that lacked the sulfhydryl 
group also leads to the investigation of phosphorus-containing 
compounds. The phosphinic acid is capable of binding to ACE in a 
manner similar to enalapril. The interaction of the zinc atom with 
the phosphinic acid is similar that is seen with sulfhydryl groups. The 
purpose of the study is to determine the ability of some derivatives 
as ACE inhibitors through docking studies and the derivative with 
the highest potency and understanding its chemical entities through 
density functional theory (DFT) studies might pave path to design of 
novel ACE inhibitors with potential inhibition activity.
METHODS
Ligand selection
A total of 10 antihypertension inhibitor molecules reported in the 
studies of Yu et al., 2015, were selected in this study to explore their 
chemical entities required for the ACE inhibitory activity. The two-
dimensional (2D) structures of compounds drawn in ACD-Chemsketch 
(Version 12) [5] were obtained as simplified molecular-input line-entry 
system (SMILES). Further, the three-dimensional (3D) structures were 
generated and converted into standard delay file format at “online 
SMILES convertor and Structure file generator” server [6].
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Target and binding site prediction
The X-ray crystal structure of human ACE complexed with lisinopril 
(PDB ID: 1O86) [7] was retrieved from protein databank [8]. The 
amino acid residues within 6 Å radius of reference ligand lisinopril was 
considered as binding site using LeadIT (Version 2.1.9) [9].
Virtual screening
The 3D structures of all the 10 selected ACE inhibitors were virtually 
screened to reveal their binding efficiencies through docking in the 
predicted binding site of ACE using FlexX module of LeadIT. The docking 
was performed with the default parameters [10-12].
Docking interactions
The docking interactions revealing Hbond and Van der Waal forces 
among the selected ACE inhibitors and the amino acid residues of ACE 
were analyzed using pose-view [13] module of LeadIT.
DFT studies
The molecular structure of the best docked compound was computed 
using Gaussian software to retrieve the molecular geometric 
coordinates. Both DFT and time-dependent DFT calculations were 
performed using Gaussian 03W software. B3LYP hybrid functional 
6-311G (d) basis set was used in the calculation methods. The models 
of the electron density of various energy levels of the compound were 
visualized using Gauss View 3.0 [14].
RESULTS AND DISCUSSION
Hypertension is a highly prevalent cardiovascular risk factor and an 
increase in BP increases the risk of developing heart disease, obesity, 
kidney disease, eye damage, and stroke. Excessive salt intake has been 
suspected as a cause of high prevalence of hypertension. A high dietary 
salt intake contributes to the risk of hypertension, which further 
antagonizes the BP-lowering effect of most antihypertensive drugs. It 
has been reported that a combination of diet rich in fruits, vegetables, 
and low-fat dairy products could substantially lower BP levels [15].
Vázquez-Valadez et al. [16] reported that main target in the treatment 
of hypertension is the ACE. This enzyme is responsible for producing 
angiotensin II, a potent vasoconstrictor. Therefore, one of the targets 
in the treatment of hypertension is to inhibit ACE activity. Hence, this 
study’s aim is to use computational studies and to demonstrate that 
the heterocyclic compounds have a molecular affinity for ACE and are 
capable of inhibiting ACE activity, thus avoiding the production of the 
vasopressor angiotensin II. The 3D structure of ACE protein as target 
is shown in Fig. 1 and the 2D structures of 10 selected heterocyclic 
compounds considered in this study are shown in Fig. 2.
Docking interactions
The docking interactions of all the selected compounds in the study 
exhibited theoretically encouraging docking scores. Among the selected 
compounds, Compound-4 has exhibited relatively good binding affinity 
as compared to the other ACE inhibitors considered in this study. The 
docking interactions of the each compound exploring the amino acids 
favoring Hbond interactions and non-bonded interactions and their 
docking scores are discussed.
Docking interactions of Compound-1
The Compound-1 showed the docking score of −11.3060 kJ/mol with the 
ACE. It is observed that the Compound-1 exhibited critical interactions 
with the catalytic amino acid residues present in the active site cavity 
of the ACE by favoring the Hbond interactions and non-bonded 
interactions. The amino acid Leu380, Phe381, and Arg110 favored the 
Hbond interactions and the non-bonded interactions are supported 
by Phe130, Phe487, Phe381, Leu382, Glu383, and Arg110. Thus, this 
compound can be considered as potential ACE inhibitor molecule. The 
docking complex and docking interactions of Compound-1 within the 
active site of ACE is shown in Fig. 3a.
Docking interactions of Compound-2
The Compound-2 showed the docking score of −17.9469 kJ/mol 
with the ACE. It is observed that the Compound-2 exhibited critical 
interactions with the catalytic amino acid residues present in the 
active site cavity of the ACE by favoring the Hbond interactions 
and non-bonded interactions. The amino acid Phe381, Arg110, 
and Leu380 favored the Hbond interactions and the non-bonded 
interactions are supported by Arg110, Glu383, Leu382, Phe130, 
Phe487, and Phe381. Thus, this compound can be considered as 
potential ACE inhibitor molecule. The docking complex and docking 
interactions of Compound-2 within the active site of ACE is shown 
in Fig. 3b.
Docking interactions of Compound-3
The Compound-3 showed the docking score of −18.9100 kJ/mol with the 
ACE. It is observed that the Compound-3 exhibited critical interactions 
with the catalytic amino acid residues present in the active site cavity 
of the ACE by favoring the Hbond interactions and non-bonded 
interactions. The amino acid Phe381, Leu380, and Arg110 favored the 
Hbond interactions and the non-bonded interactions are supported 
by Phe487, Arg110, Leu382, Phe381, Glu383, and Phe130. Thus, this 
compound can be considered as potential ACE inhibitor molecule. The 
docking complex and docking interactions of Compound-3 within the 
active site of ACE is shown in Fig. 3c.
Docking interactions of Compound-4
The Compound-4 showed the highest docking score of −26.6290 kJ mol 
with the ACE. It is observed that the Compound-4 exhibited critical 
interactions with the catalytic amino acid residues present in the active 
site cavity of the ACE by favoring the Hbond interactions and non-bonded 
interactions. The amino acid Phe381, Leu380, and Arg110 favored the 
Hbond interactions and the non-bonded interactions are supported 
by Arg110, Glu383, Leu382, Phe130, Phe487, and Phe381. Thus, this 
compound can be considered as potential ACE inhibitor molecule. The 
docking complex and docking interactions of Compound-4 within the 
active site of ACE is shown in Fig. 3d.
Docking interactions of Compound-5
The Compound-5 showed the docking score of −14.2283 kJ/mol with the 
ACE. It is observed that the Compound-5 exhibited critical interactions 
with the catalytic amino acid residues present in the active site cavity 
of the ACE by favoring the Hbond interactions and non-bonded 
interactions. The amino acid Phe381, Leu380, and Arg110 favored the 
Hbond interactions and the non-bonded interactions are supported 
by Arg110, Glu383, Leu382, Phe130, Phe487, and Phe381. Thus, this 
compound can be considered as potential ACE inhibitor molecule. The 
docking complex and docking interactions of Compound-5 within the 
active site of ACE is shown in Fig. 3e.
Fig. 1: The protein structure of human angiotensin-converting 
enzyme complexed with lisinopril (PDB ID: 1O86)
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Docking interactions of Compound-6
The Compound-6 showed the docking score of −11.1612 kJ/mol with the 
ACE. It is observed that the Compound-6 exhibited critical interactions 
with the catalytic amino acid residues present in the active site cavity 
of the ACE by favoring the Hbond interactions and non-bonded 
interactions. The amino acid Phe381, Leu380, and Arg110 favored the 
Hbond interactions and the non-bonded interactions are supported 
by Arg110, Glu383, Leu382, Phe130, Phe487, and Phe381. Thus, this 
compound can be considered as potential ACE inhibitor molecule. The 
docking complex and docking interactions of Compound-6 within the 
active site of ACE is shown in Fig. 3f.
Docking interactions of Compound-7
The Compound-7 showed the docking score of −15.9906 kJ/mol 
with the ACE. It is observed that the Compound-7 exhibited critical 
interactions with the catalytic amino acid residues present in the 
active site cavity of the ACE by favoring the Hbond interactions 
and non-bonded interactions. The amino acid Phe381, Leu380, 
and Arg110 favored the Hbond interactions and the non-bonded 
interactions are supported by Arg110, Glu383, Leu382, Phe130, 
Phe487, and Phe381. Thus, this compound can be considered as 
potential ACE inhibitor molecule. The docking complex and docking 
interactions of Compound-7 within the active site of ACE is shown 
in Fig. 3g.
Docking interactions of Compound-8
The Compound-8 showed the docking score of −17.1659 kJ/mol with the 
ACE. It is observed that the Compound-8 exhibited critical interactions 
with the catalytic amino acid residues present in the active site cavity 
of the ACE by favoring the Hbond interactions and non-bonded 
interactions. The amino acid Phe381, Leu380, and Arg110 favored the 
Hbond interactions and the non-bonded interactions are supported 
by Arg110, Glu383, Leu382, Phe130, Phe487, and Phe381. Thus, this 
compound can be considered as potential ACE inhibitor molecule. The 
docking complex and docking interactions of Compound-8 within the 
active site of ACE is shown in Fig. 3h.
Docking interactions of Compound-9
The Compound-9 showed the docking score of −15.7295 kJ/mol with the 
ACE. It is observed that the Compound-9 exhibited critical interactions 
with the catalytic amino acid residues present in the active site cavity 
of the ACE by favoring the Hbond interactions and non-bonded 
interactions. The amino acid Phe381, Leu380, and Arg110 favored the 
Hbond interactions and the non-bonded interactions are supported by 
Fig. 2: The two-dimensional structure of 10 selected heterocyclic compounds
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Phe487, Phe381, Gly379, Phe130, Trp116, Thr318, Phe231, Leu382, 
Ile488, and Arg110. Thus, this compound can be considered as potential 
ACE inhibitor molecule. The docking complex and docking interactions 
of Compound-9 within the active site of ACE is shown in Fig. 3i.
Docking interactions of Compound-10
The Compound-10 showed the docking score of −14.7761 kJ/mol 
with the ACE. It is observed that the Compound-10 exhibited critical 
interactions with the catalytic amino acid residues present in the active 
site cavity of the ACE by favoring the Hbond interactions and non-bonded 
interactions. The amino acid Phe381, Leu380, and Arg110 favored the 
Hbond interactions and the non-bonded interactions are supported 
by Arg110, Glu383, Leu382, Phe130, Phe487, and Phe381. Thus, this 
compound can be considered as potential ACE inhibitor molecule. The 
docking complex and docking interactions of Compound-10 within the 
active site of ACE is shown in Fig. 3j.
DFT studies
Among the selected 10 ACE inhibitors, the Compound-4 exhibited the 
highest docking score, and thus, the Compound-4 was considered to 
explore its structural features and also the chemical entities required 
for the activity of the compound. The compound geometry was 
analyzed through predicting Fourier transform infrared (FT-IR) and 
FT Raman spectra of the optimized Compound-4. Further, considering 
that the determination of the energy gap between highest occupied 
molecular orbital (HOMO) and lowest unoccupied molecular orbitals 
(LUMO) could provide the chemical reactivity and kinetic stability 
of molecules, the Compounds 4 was optimized and proposed for 
theoretical calculations (DFT studies) using Gaussian software.
Vibrational analysis
The vibration spectral analysis is performed on the basis of the 
characteristic vibrations of the amino group, hydroxyl group, carbonyl 
group, and methyl group. The optimized 3D structure of Compound-4 
is shown in Fig. 4.
The theoretically predicted FT-IR and FT Raman spectra using 
B3LYP/6-311 G (d,p) method and the observed experimental FT-IR 
and FT Raman spectra are shown in Figs. 5 and 6, respectively. The 
respective FT-IR spectra and FT Raman spectra were recorded in the 
range from 4000 to 400 cm−1.
The Compound-4 exhibits a sharp peak at 2000 cm−1 associated with 
the –C–H– stretching vibrations of CH and CH3 groups. The signal 
characteristic bands of C=O (carbonyl) stretching vibration at 1600–
1750 cm−1 are due to the presence of some aromatic esters.
The compounds containing methyl groups and C-H groups are electron 
donating substituent in the aromatic ring system. Absorption arising 
from C–H stretching in the alkenes occurs in the region 3000–2840 cm−1. 
The lowering of the wave numbers from the normal values is due to the 
intermolecular charge transfer from the dimethyl group to the hydroxyl 
group through π conjugation system.
The changes in intensity of the CH3 stretching mode are also due to 
the influence of electronic effects resulting from hyperconjugation of 
methyl group with nitrogen atom and the aromatic ring system. Thus, 
the hyperconjugation of methyl group, causing changes in intensity 
in IR, clearly indicates that methyl hydrogen is directly involved in the 
donation of electronic charge. The asymmetric and symmetric bending 
Fig. 4: The optimized geometry of the Compound-4
Fig. 3 (a) Docking complex and interactions of Compound-1 with angiotensin-converting enzyme (ACE) (Score: −11.3060 kJ/mol). 
(b) Docking complex and interactions of Compound-2 with ACE (Score: −17.9469 kJ/mol). (c) Docking complex and interactions 
of Compound-3 with ACE (Score: −18.9100 kJ/mol). (d) Docking complex and interactions of Compound-4 with ACE 
(Score: −26.6290 kJ/mol). (e) Docking complex and interactions of Compound-5 with ACE (Score: −14.2283 kJ/mol). (f) Docking complex 
and interactions of Compound-6 with ACE (Score: −11.1612kJ/mol). (g) Docking complex and interactions of Compound-7 with ACE 
(Score: −15.9906 kJ/mol). (h) Docking complex and interactions of Compound-8 with ACE (Score: −17.1659 kJ/mol). (i) Docking complex 
and interactions of Compound-9 with ACE (Score: −15.7295 kJ/mol). (j) Docking complex and interactions of Compound-10 with ACE 
(Score: −14.7761 kJ/mol)
a b c d
e f g h
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vibrations of methyl group normally appear around 1446 and 1375 cm−1, 
respectively. The relatively large value of intensity in IR and Raman wave 
numbers of the rocking modes suggests the presence of hyperconjugation. 
The twisting and torsion vibrations are identified below 503 cm−1, which 
are also supported by the computed wave numbers.
The fundamental modes involving the amino group are stretching and 
bending of NH bonds, torsion, and inversion. The Compound-4 under 
investigation possesses one NH2 group, and hence, one expects one 
symmetric and one asymmetric N–H stretching vibrations. In all the 
primary aromatic amines, the N–H stretching frequency occurs in the 
region 3300–3500 cm−1 and. The antisymmetric stretching mode appears 
to be higher wave number than the symmetric. In Compound-4, the NH2 
asymmetric stretching vibration is observed in IR at 2500 as a medium 
band; the symmetric stretching vibration is observed in IR around 3520 
cm−1 and in Raman around 3580 cm−1. The frequency lowering present in 
the molecule is due to the intermolecular interaction.
The ring modes which are found to be active in both IR and Raman 
spectra enable the molecule to be an effective π conjugation system. 
Due to the existence of one directional charge transfer from the 
donor to the acceptor through the single-double bond conjugated 
path induces large variations of both the molecular dipole moment 
and the molecular polarizability during the same vibrations, thus 
gaining the activity of both IR and Raman at the same time. The 
simultaneous activation of IR and Raman ring modes also supports 
the charge transfer interaction between CH3 and the aromatic 
ring which also plays an important role in the biological activity 
of the compound to establish as a pharmaceutical compound with 
inhibitory activities.
Natural bond analysis (HOMO-LUMO)
The Eigenvalue of LUMO-HOMO energy gap reflects the chemical 
activity of the molecule. The HOMO-LUMO plot of Compound-4 is 
shown in Fig. 7. The calculated HOMO of −4.46eV and LUMO of −2.86 
eV are observed.
The decrease in the HOMO and LUMO energy gap (1.60 eV) explains the 
eventual charge transfer interaction taking place within the molecule, 
due to the strong electron-accepting ability of the electron-acceptor 
group. It is worth noting that HOMOs have an overall π bonding 
character along with a considerable non-bonding character and 
LUMOs have an antibonding π* character. The strong charge transfer 
interaction is responsible for the bioactivity of the molecule.
Molecular electrostatic potentials
The electrostatic contour map of the Compound-4 is shown in Fig. 8. The 
blue contours indicate electropositive charges correlating with activity and 
the Hbond donor regions, and the red contour indicates the relationship 
between negative charge and activity and also the Hbond acceptor regions.
The increase in positive charge and H-bond donor regions are favored 
in blue region while increase in negative charge and H-bond acceptor 
regions are favored in red region. Blue-colored regions show areas 
where electropositive charged groups enhance inhibitory activity by 
the presence of H-bond donors, while red regions represent where 
electronegative charged groups improve the activity with the presence of 
H-bond acceptors. The green colored contours indicates the steric bulk 
groups that are required to increase the activity while the yellow contours 
indicates the unfavorable steric bulk groups that can decrease the activity.
Thus, considering the docking interactions of Compound-4 with ACE 
protein and geometry, HOMO-LUMO energy gaps and electrostatic 
contour map of the Compound-4 clearly envisage that the presence 
of electropositive charged groups is very essential to enhance the 
inhibitory activity along with the H-bond donors, and the presence of 
electronegative charged groups can possibly improve the activity along 
the presence of H-bond acceptors.
Fig. 5: Theoretical Fourier transform infrared of Compound-4
Fig. 6: Theoretical Fourier transform Raman spectra of 
Compound-4 Fig. 8: Electrostatic contour map of the Compound-4
Fig. 7: The highest occupied molecular orbital-lowest unoccupied 
molecular orbitals plot of the Compound-4
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CONCLUSION
Hypertension is an important risk factor, contributing to other 
cardiovascular diseases such as blood vessel disorders, coronary 
heart disease, aortic aneurysm, and stroke. The search for many novel 
ACE inhibitors is in progress that can be effective in the treatment 
of hypertension. Hence, the clear understanding of the present ACE 
inhibitors might give envisage the required chemical entities for the 
better ACE inhibition activity. Thus, in this study, a set of ACE inhibitors 
is used to explore their binding mechanisms with ACE protein and the 
Compound-4 with the highest activity is considered for further DFT 
analysis. The DFT studies revealed the HOMO (−4.46eV) and LUMO 
(−2.86 eV) and the energy gap (1.60 eV). This NBO analysis explained the 
eventual charge transfer is due to the strong electron-accepting ability 
of the compound. Furthermore, the electrostatic contour map revealed 
that the presence of electropositive charged groups is very essential to 
enhance the inhibitory activity along with the H-bond donors, and the 
presence of electronegative charged groups can possibly improve the 
activity along the presence of H-bond acceptors.
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